BBH holdings
VanEck Biotech ETF
Positions
25 stored of 25 reported, largest first by weight
| # | Holding | ISIN | CUSIP | Weight | Value (USD) | Type | Issuer type | Country | Currency |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Amgen Inc | US0311621009 | 031162100 | 15.249% | $60.3M | Equity (common) | Corporate | United States | USD |
| 2 | Gilead Sciences Inc | US3755581036 | 375558103 | 12.787% | $50.6M | Equity (common) | Corporate | United States | USD |
| 3 | Vertex Pharmaceuticals Inc | US92532F1003 | 92532F100 | 9.103% | $36.0M | Equity (common) | Corporate | United States | USD |
| 4 | Regeneron Pharmaceuticals Inc | US75886F1075 | 75886F107 | 6.209% | $24.6M | Equity (common) | Corporate | United States | USD |
| 5 | Revolution Medicines Inc | US76155X1000 | 76155X100 | 5.273% | $20.9M | Equity (common) | Corporate | United States | USD |
| 6 | Argenx SE | US04016X1019 | 04016X101 | 4.972% | $19.7M | Equity (common) | Corporate | Netherlands | USD |
| 7 | Natera Inc | US6323071042 | 632307104 | 4.919% | $19.5M | Equity (common) | Corporate | United States | USD |
| 8 | IQVIA Holdings Inc | US46266C1053 | 46266C105 | 4.306% | $17.0M | Equity (common) | Corporate | United States | USD |
| 9 | Alnylam Pharmaceuticals Inc | US02043Q1076 | 02043Q107 | 3.832% | $15.2M | Equity (common) | Corporate | United States | USD |
| 10 | Biogen Inc | US09062X1037 | 09062X103 | 3.627% | $14.3M | Equity (common) | Corporate | United States | USD |
| 11 | Moderna Inc | US60770K1079 | 60770K107 | 3.363% | $13.3M | Equity (common) | Corporate | United States | USD |
| 12 | Illumina Inc | US4523271090 | 452327109 | 3.171% | $12.5M | Equity (common) | Corporate | United States | USD |
| 13 | United Therapeutics Corp | US91307C1027 | 91307C102 | 2.826% | $11.2M | Equity (common) | Corporate | United States | USD |
| 14 | BeOne Medicines Ltd | US07725L1026 | 07725L102 | 2.809% | $11.1M | Equity (common) | Corporate | Switzerland | USD |
| 15 | Insmed Inc | US4576693075 | 457669307 | 2.670% | $10.6M | Equity (common) | Corporate | United States | USD |
| 16 | Incyte Corp | US45337C1027 | 45337C102 | 2.492% | $9.9M | Equity (common) | Corporate | United States | USD |
| 17 | Neurocrine Biosciences Inc | US64125C1099 | 64125C109 | 2.082% | $8.2M | Equity (common) | Corporate | United States | USD |
| 18 | BioNTech SE | US09075V1026 | 09075V102 | 1.942% | $7.7M | Equity (common) | Corporate | Germany | USD |
| 19 | ICON PLC | IE0005711209 | Not reported | 1.902% | $7.5M | Equity (common) | Corporate | Ireland | USD |
| 20 | Bio-Techne Corp | US09073M1045 | 09073M104 | 1.542% | $6.1M | Equity (common) | Corporate | United States | USD |
| 21 | Charles River Laboratories International Inc | US1598641074 | 159864107 | 1.502% | $5.9M | Equity (common) | Corporate | United States | USD |
| 22 | BioMarin Pharmaceutical Inc | US09061G1013 | 09061G101 | 1.339% | $5.3M | Equity (common) | Corporate | United States | USD |
| 23 | QIAGEN NV | NL0015002SN0 | Not reported | 1.065% | $4.2M | Equity (common) | Corporate | Netherlands | USD |
| 24 | Tempus AI Inc | US88023B1035 | 88023B103 | 0.983% | $3.9M | Equity (common) | Corporate | United States | USD |
| 25 | State Street Global Advisors State Street Navigator Securities Lending Government Money Market Portfolio | US8574927062 | 857492706 | 0.059% | $234K | Short-term investment vehicles (cash funds) | Registered fund | United States | USD |